目的研究环维黄杨星D(cyclovirobuxineD,Cvb.D)对阿霉素(doxorubicin,DOX)所致小鼠心脏毒性的影响。方法52只C57小鼠分为4组(n:12):正常对照组(Contr01)、Cvb.D组、DOX组和Cvb.D+DOX组,每天灌胃给予Cvb—D(1mg/kg)或生理盐水,连续给药4d,第5天单次腹腔注射DOX(15mekg)或生理盐水。心肌组织切片进行Masson’S染色,光镜下观察各组小鼠心肌组织纤维化改变;测定血清乳酸脱氢酶(LDH)、肌酸激酶(CK)水平及组织Caspase-3活性;采用末端标记TUNEL法检测各组心肌细胞凋亡情况;利用Westernblot法检测Bcl-2和Bax蛋白表达水平及其比值。结果与正常对照组相比,Cvb—D预处理可明显抑制DOX引起的体质量下降(P〈0.05)以及心肌纤维化等组织形态学改变,显著抑制DOX引起的LDH、CK及Caspase-3活性升高(P〈0.05),缓解DOX引起的心肌细胞凋亡,并显著提高DOX诱导的Bcl-2/Bax蛋白表达比值降低(P〈0.05)。结论Cvb.D对DOX心脏毒性具有保护作用,并能够改善DOX引起的细胞凋亡。
Objective To observe the effect of cyclovirobuxine D (Cvb-D) on mice suffered from doxorubicin (DOX)-induced cardiotoxicity. Methods Adult C57 mice were randomly divided into four groups (n = 12) including a control group, a Cvb-D group, a DOX group and a Cvb-D + DOX group. Mice were given Cvb-D (1 mg/kg) intragastrically once a day for 4 consecutive days, followed by a single intraper- itoneal injection of DOX (15 mg/kg) or saline, and the body weight was recorded thereafter. Four days later, the serum levels of creatine kinase (CK) and lactate dehydrogenase (LDH) and the activity of myocardial caspase-3 were determined, and cardiac tissue sections were stained with Masson' s trichrome to observe the morphology of myoeardium. Apoptotie cells in cardiac tissues were observed by TUNEL assay. The protein expression levels of Bcl-2 and Bax were determined by Western blotting, and the ratio of Bcl-2/Bax was calcu- lated. Results Cvb-D administered alone had no obvious effect on mice as compared with the control group. Pretreatment with Cvb-D significantly rescued DOX-induced decrease of body weight in mice (P 〈 0.05), and alleviated myocardial fibrosis. Cvb-D significantly inhibited DOX-induced increase in serum levels of LDH and CK and caspase-3 activity (P 〈 0. 05 ) in cardiac tissues, and relieved DOX-induced myocardial apoptosis. Cvb-D also improved the ratio of Bcl-2/Bax expression decreased by DOX. Conclusion Cvb-D has a protec- tive effect against DOX-induced cardiotoxicity possibly by inhibiting cell apoptosis.